XML 47 R35.htm IDEA: XBRL DOCUMENT v3.25.1
Revenue Recognition (Tables)
3 Months Ended
Mar. 31, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table represents Evolent’s revenue disaggregated by line of business and product type (in thousands):
For the Three Months Ended March 31,
20252024
Medicaid$188,124 $215,124 
Medicare115,318 286,960 
Commercial and other180,207 137,569 
Total$483,649 $639,653 
Performance Suite$303,021 $448,218 
Specialty Technology and Services Suite82,821 89,003 
Administrative Services57,191 58,569 
Cases40,616 43,863 
Total$483,649 $639,653 
Schedule of Contract with Customer, Asset and Liability
The following table provides information about receivables, contract assets and deferred revenue from contracts with customers as of March 31, 2025 and December 31, 2024 (in thousands):
March 31, 2025December 31, 2024
Short-term receivables (1)
$429,161 $413,346 
Short-term deferred revenue5,017 2,507 
————————
(1)Excludes pharmacy rebate receivable and pharmacy claims receivable.

Changes in deferred revenue for the three months ended March 31, 2025 are as follows (in thousands):
Deferred revenue
Balance as of beginning-of-period$2,507 
Reclassification to revenue, as a result of performance obligations satisfied(1,093)
Cash received in advance of satisfaction of performance obligations3,603 
Balance as of end of period$5,017